Drospirenone, ethinyl estradiol, and levomefolate and Omalizumab Subcutaneous
Determining the interaction of Drospirenone, ethinyl estradiol, and levomefolate and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: drospirenone / ethinyl estradiol / levomefolate calcium
Brand name: Beyaz, Safyral, Rajani, Tydemy
Synonyms: Ethinyl Estradiol, Drospirenone, and Levomefolate
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Drospirenone, ethinyl estradiol, and levomefolate-Ombitasvir, Paritaprevir, and Ritonavir
- Drospirenone, ethinyl estradiol, and levomefolate-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Drospirenone, ethinyl estradiol, and levomefolate-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Drospirenone, ethinyl estradiol, and levomefolate-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Drospirenone, ethinyl estradiol, and levomefolate-Omeclamox-Pak
- Drospirenone, ethinyl estradiol, and levomefolate-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-DroTuss-CP
- Omalizumab Subcutaneous-Droxia
- Omalizumab Subcutaneous-Droxidopa
- Omalizumab Subcutaneous-Dry Eye Omega Benefits
- Omalizumab Subcutaneous-DryMax
- Omalizumab Subcutaneous-DryMax Syrup